The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

ClinicoEconomics and Outcomes Research

Volumn 3, Issue 1, 2011, Pages 15-18

  Ozkaya, Sevket ^a   Findik, Serhat ^b   Atici, Atilla Guven ^b  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Acute exacerbation; COPD; Costs; Hospitalization

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE EXACERBATION; DRUG COST; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HOSPITAL BED; HOSPITAL LABORATORY; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; LUNG CANCER; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RADIOLOGY DEPARTMENT; RESPIRATORY FAILURE; TURKEY (REPUBLIC);

EID: 79952922265     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S14820     Document Type: Article

References (20)

1. Hurd S. The impact of COPD on lung health worlwide: epidemiology and incidence. Chest. 2000;117:1S-4S.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
3. Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, treatment and prevention of chronic obstructive pulmonary disease; 2006. Available from: http://www.goldcopd.com. Accessed 2010 Dec 10.
4. Miravitlles M, Murio C, Guerrero T, Gisbert R. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121:1449-1455.
5. Rutten van Molken MP, Postma MJ, Joore MA, et al. Current and future medical costs of asthma and COPD in The Netherlands. Respir Med. 1999;93:779-787.
6. Hilleman DE, Dewan N, Malesker M, et al. Pharmacoeconomic evaluation of COPD. Chest. 2000;118:1276-1285.
7. Seemungal TAR, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD - a review of potential interventions. Int J COPD. 2009;4:203-223.
8. Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459-467.
9. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117(Suppl 5S):5S-9S.
10. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe COPD: the SUPPORT Investigators (Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154:959-967.
11. Jacobson L, Hertzman P, Löfdahl CG, et al. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweeden in 1980 and 1991. Respir Med. 2000;94:247-255.
12. Wilson L, Devine EB, So K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med. 2000;94:204-213.
13. Andersson F, Borg S, Jansson S-A, Jonsson A-C, et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med. 2002;96:700-708.
14. Chen Y, Yao WZ, Cai BQ, et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chin Med J. 2008;121:587-591.
15. Nurmagambetov T, Atherly A, Williams S, Holguin F, Mannino DM, Redd SC. What is the costs to employers of direct medical car efor chronic obstructive pulmonary disease? COPD. 2006;3:20-39.
16. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117:1S-4S.
17. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995; 274:1852-1857.
18. Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med. 1995;98:272-277.
19. Mushlin AI, Black ER, Connoly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266:80-83.
20. Skrepnek GH, Skrepnek MD. Epidemiology, clinical and economic burden, and natural history of chronic pulmonary disease and asthma. Am J Manag Care. 2004;10:129-138.